+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NATHBIOGEN

Nath Bio-Genes (India) Share Price

₹141.72 +0.78 (0.55%)
30.53% Fall from 52W High

13 Nov, 2026 3:52 PM (IST)

Nath Bio-Genes (India) live price: ₹141.72. It opened at ₹141 vs previous close ₹141; intraday high/low: ₹145/₹139. The 50 & 200 DMA stand at ₹141.20/₹153.40.

Nath Bio-Genes (India) Performance

  • Today's Low
  • ₹139
  • Today's High
  • ₹145
  • 52 Week Low
  • ₹126
  • 52 Week High
  • ₹204
  • Open Price₹141
  • Previous Close₹141
  • Volume15,024
  • 50 DMA₹141.20
  • 100 DMA₹147.20
  • 200 DMA₹153.40

Nath Bio-Genes (India) Chart

Investment Returns

  • Over 1 Month + 1.29%
  • Over 3 Month -8.6%
  • Over 6 Month -11.85%
  • Over 1 Year -15.3%

Smart Investing Starts Here Start SIP with Nath Bio-Genes (India) for Steady Growth!

Invest Now

Nath Bio-Genes (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.9
  • PEG Ratio
  • -0.4
  • Market Cap Cr
  • 269
  • P/B Ratio
  • 0.4
  • Average True Range
  • 4.4
  • EPS
  • 18
  • Dividend Yield
  • 1.4
  • MACD Signal
  • 0.1
  • RSI
  • 61
  • MFI
  • 87.49

Latest Stock News Updates

Nath Bio-Genes (India) Ltd - 537291 - Financial Results - Outcome Of Board Meeting

Unaudited Standalone and Consolidated Financial Results as on 30th September 2026

Nath Bio-Genes (India) Ltd - 537291 - Earning Call

Intimation about Conference call to be held on 16th November 2026 at 04:00 PM

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Financial Results

Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended 30th September 2026

Nath Bio-Genes (India) Financials

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹141.72
+ 0.78 (0.55%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹137.40
  • 50 Day
  • ₹141.20
  • 100 Day
  • ₹147.20
  • 200 Day
  • ₹153.40

Resistance and Support

141.81 Pivot Speed
  • R3 151.20
  • R2 148.10
  • R1 144.90
  • S1 138.60
  • S2 135.50
  • S3 132.30

Nath Bio-Genes (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Quarterly Results
2026-07-29 Quarterly Results
2026-05-04 Audited Results & Final Dividend
2026-01-31 Quarterly Results
2025-11-13 Quarterly Results
Date Purpose Remarks
2026-09-11 FINAL Rs.2.00 per share(20%)Final Dividend
2025-08-14 FINAL Rs.2.00 per share(20%)Final Dividend
2024-08-09 FINAL Rs.2.00 per share(20%)Final Dividend
View Nath Bio-Genes (India) Dividend History Arrow

Nath Bio-Genes (India) Shareholding Pattern

54.21%
45.6%
0.18%
0.01%
0%

About Nath Bio-Genes (India)

Nath Bio-Genes (India) engaged in the business of research, development, production, processing and marketing of hybrid and varietal seeds for field crops and vegetables, catering to the agricultural needs of farmers across India and international markets View More
  • NSE Symbol
  • NATHBIOGEN
  • BSE Symbol
  • 537291
  • Managing Director
  • Mr. Satish Kagliwal
  • ISIN
  • INE448G01010

Similar Stocks to Nath Bio-Genes (India)

Nath Bio-Genes (India) FAQs

Nath Bio-Genes (India) share price is ₹141 As on 15 November, 2026 | 22:08

The Market Cap of Nath Bio-Genes (India) is ₹269.3 Cr As on 15 November, 2026 | 22:08

The P/E ratio of Nath Bio-Genes (India) is 7.9 As on 15 November, 2026 | 22:08

The PB ratio of Nath Bio-Genes (India) is 0.4 As on 15 November, 2026 | 22:08

The 52 week High & Low of Nath Bio-Genes (India) is ₹204/₹126.2 respectively As on 15 November, 2026 | 22:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23